Mirum Pharmaceuticals Inc (MIRM)
40.44
+0.04
(+0.10%)
USD |
NASDAQ |
Nov 04, 16:00
40.48
+0.04
(+0.10%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Assets (Quarterly): 660.75M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 660.75M |
| March 31, 2024 | 651.96M |
| December 31, 2023 | 646.62M |
| September 30, 2023 | 650.64M |
| June 30, 2023 | 443.59M |
| March 31, 2023 | 333.53M |
| December 31, 2022 | 352.91M |
| September 30, 2022 | 364.35M |
| June 30, 2022 | 297.23M |
| March 31, 2022 | 278.15M |
| December 31, 2021 | 294.65M |
| Date | Value |
|---|---|
| September 30, 2021 | 235.17M |
| June 30, 2021 | 247.67M |
| March 31, 2021 | 222.24M |
| December 31, 2020 | 240.86M |
| September 30, 2020 | 141.86M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 172.80M |
| December 31, 2019 | 146.71M |
| September 30, 2019 | 158.27M |
| June 30, 2019 | 104.27M |
| March 31, 2019 | 51.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
141.86M
Minimum
Sep 2020
660.75M
Maximum
Jun 2024
344.08M
Average
294.65M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Cytokinetics Inc | 1.524B |
| MannKind Corp | 443.84M |
| TG Therapeutics Inc | 401.21M |
| Ocugen Inc | 40.54M |
| Rhythm Pharmaceuticals Inc | 381.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 431.77M |
| Shareholders Equity (Quarterly) | 228.99M |
| Debt to Equity Ratio | 1.342 |
| Current Ratio | 3.275 |
| Net Debt Paydown Yield | -3.78% |